The aim of the study was to prospectively gather data on the outcomes of prenatally diagnosed Trisomy 21 (T21) in a large tertiary referral centre. Our aim was to examine the termination rate and the rate of fetal loss in those who chose to continue including miscarriage and stillbirth. STUDY DESIGN: Data was gathered prospectively in a large tertiary referral centre over 5 years from 2013-2017 inclusively. Baseline demographic and delivery details were recorded on an anonymized computerized database, these data are subject to continuous audit. The gestation at diagnosis, associated anomalies and the nature of diagnostic tests were recorded. Outcomes including termination of pregnancy (TOP), miscarriage, stillbirth and neonatal death were recorded. The mode of delivery and associated complications were also recorded. Unpaired t-tests were used to compare continuous data and chi-square tests to compare categorical data. Multiple logistic regression was used to calculate adjusted odds ratios. RESULTS: There were a total of 44,750 deliveries in the study period. There were 1836 congenital anomalies diagnosed in the study period including 165 (8.9%) cases of Trisomy 21. There was incidence therefore of 0.3% or 1 in 330 for prenatally diagnosed T21. Full outcome data was available in 112 cased. 76 (67%) women choose a termination of pregnancy following a diagnosis of T21. There were 4 second trimester miscarriages (11%) and 10 stillbirths (27%) in those that did not undergo a termination of pregnancy. The total fetal loss rate in those that did not undergo termination was 38%. CONCLUSION: T21 is one of the most common conditions encountered in fetal medicine. In this jurisdiction termination of pregnancy is illegal at present and requires travel abroad, leading to a lower termination rate. This allows the natural history to be observed. The risk of fetal loss in prenatally diagnosed T21 is relatively high at 30%. This information may be of benefit when counselling those who choose to continue their pregnancy or in settings where there is limited access to termination of pregnancy.
OBJECTIVE:
The Management of Myelomeningocele Study (MOMS) trial reported that in utero fetal surgery for myelomeningocele repair (fMMC) resulted in reversal of hindbrain herniation and decreased need for ventriculoperitoneal shunt (VPS). Fetuses with preoperative ventricle size (VS) ! to 15 mm, however, were less likely to realize this benefit. In this study, we analyzed the trend in VS throughout gestation to determine whether it is a predictor of VPS. STUDY DESIGN: This is a secondary analysis of prospectively collected data of consecutive cases with fetal myelomeningocele evaluated and delivered at our institute (January 2012 to May 2018). VS measurements were obtained as outlined by the ISUOG guidelines and reviewed by the Fetal Surgeons. Women with initial VS ! 15 mm were excluded. Two groups were identified: Group 1 -women who had fetal surgery (fMMC), Group 2 -women whose neonates had postnatal repair (PNR). Criteria for VPS was similar for both groups. Ultrasound measurements of VS for each 2-week epoch of gestational age (GA) were compared between the groups. Penalized Bsplines were used to fit the VS data over GA for each group. To determine whether VS was predictive of postnatal VPS, receiver operator curves (ROCs) were used to determine the optimal VS cutoff values for each 2-week epoch. Sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV) and positive/negative likelihood ratios (LLR) were calculated at the cutoffs determined by the ROCs. RESULTS: 95 women met inclusion criteria; 55 (58%) had fMMC repair and 40 (42%) had PNR. VPS rates were 36% and 65% respectively (p < 0.01). VS was similar between each group at all GAs except for 30 e 32 weeks (18.3 AE 5.6 vs. 14.3 AE 6.8, p < 0.01 Table 1 . Penalized B-splines show VS increasing continuously with GA for each group (Figure 1) . ROC analysis showed that VS at 28 e 30 weeks is most predictive of VPS (area under ROC ¼ 0.70, 95% CI 0.55 e 0.86). At this GA, a VS cutoff of 18 mm had SN of 60%, SP of 89%, PPV of 83%, and NPV of 71% for prediction of VPS (LLR+ 5.5, Table1) . Test statistics at other GA epochs were similar and the optimal cutoff increased continuously with GA. CONCLUSION: Overall VS is weakly predictive of the need for postnatal VPS. However, at 28 e 30 weeks GA, fetuses with VS greater than 18 mm are at moderately increased risk of requiring postnatal VPS. Postnatal factors resulting in the increased need for VPS in the PNR group needs to be assessed further.
